1. Home
  2. BDTX vs NPV Comparison

BDTX vs NPV Comparison

Compare BDTX & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • NPV
  • Stock Information
  • Founded
  • BDTX 2014
  • NPV 1993
  • Country
  • BDTX United States
  • NPV United States
  • Employees
  • BDTX N/A
  • NPV N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • NPV Investment Managers
  • Sector
  • BDTX Health Care
  • NPV Finance
  • Exchange
  • BDTX Nasdaq
  • NPV Nasdaq
  • Market Cap
  • BDTX 181.4M
  • NPV 211.4M
  • IPO Year
  • BDTX 2020
  • NPV N/A
  • Fundamental
  • Price
  • BDTX $3.99
  • NPV N/A
  • Analyst Decision
  • BDTX Strong Buy
  • NPV
  • Analyst Count
  • BDTX 5
  • NPV 0
  • Target Price
  • BDTX $12.00
  • NPV N/A
  • AVG Volume (30 Days)
  • BDTX 1.0M
  • NPV 38.9K
  • Earning Date
  • BDTX 11-04-2025
  • NPV 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • NPV 3.90%
  • EPS Growth
  • BDTX N/A
  • NPV N/A
  • EPS
  • BDTX 0.25
  • NPV N/A
  • Revenue
  • BDTX $70,000,000.00
  • NPV N/A
  • Revenue This Year
  • BDTX N/A
  • NPV N/A
  • Revenue Next Year
  • BDTX N/A
  • NPV N/A
  • P/E Ratio
  • BDTX $15.96
  • NPV N/A
  • Revenue Growth
  • BDTX N/A
  • NPV N/A
  • 52 Week Low
  • BDTX $1.20
  • NPV $8.92
  • 52 Week High
  • BDTX $4.10
  • NPV $11.55
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 69.63
  • NPV 50.20
  • Support Level
  • BDTX $3.81
  • NPV $11.42
  • Resistance Level
  • BDTX $4.03
  • NPV $11.63
  • Average True Range (ATR)
  • BDTX 0.20
  • NPV 0.08
  • MACD
  • BDTX 0.04
  • NPV -0.03
  • Stochastic Oscillator
  • BDTX 91.58
  • NPV 14.12

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About NPV Nuveen Virginia Quality Municipal Income Fund

Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.

Share on Social Networks: